A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...).

The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit.

The second aim is to assess the satisfaction of patients and health care teams.

PASSION is a french monocentric study.

For the retrospective cohort, patient will be selected through the use of data warehouse available on the HEGP.

For the prospective cohort, patient will be included according to the selection criteria.

Each patient will be followed up during 6 month and a satisfaction questionnaire will be completed at 1 month and 4 month of the first administration of anti-tumor therapy.

For both cohort, clinical-anatomo-biological data will be collected through the use of data warehouse available on the HEGP.

Inclusion Criteria:

• Histologically proven : colon, gastric, pancreatic, prostate, bladder, breast, thoracic, or ovarian cancer
• First appointment for cancer care at the Hôpital Européen Georges Pompidou
• Intravenous antitumoral treatment

Exclusion Criteria:

• Medical care non covered by social welfare
• Radiochemotherapy
• Death in the 6 months following first oncological appointment or absence of medical care in the year following the first oncological appointment

Retrospective cohort: patients treated at the Hôpital Européen Georges Pompidou in 2015 and 2017.

Prospective cohort:

• Histologically proven : colon, gastric, pancreatic, prostate, bladder, breast, thoracic, or ovarian cancer
• First appointment for cancer care at the Hôpital Européen Georges Pompidou
• Ile de France resident
• All appointments planned at the Hôpital Européen Georges Pompidou
• Intravenous antitumoral treatment

one year after the last publication

Data sharing must be accepted by the sponsor and the PI based on scientific project and scientific involvement of the PI team.

Teams wishing obtain IPD must meet the sponsor and IP team to present scientifics (and commercial) purpose, IPD needed, format of data transmission, and timeframe. Technical feasibility and financial support will be discussed before mandatory contractualization